Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

December 31, 2021

Conditions
Covid19Myeloma MultipleMalignant LymphomaHematologic NeoplasmsStem Cell Transplant Complications
Interventions
OTHER

Autologous stem cell transplantation

The study will describe the implications of COVID-19 infection following autologous stem cell transplantation

Trial Locations (1)

Unknown

Uppsala Universitet, Uppsala

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Lund University Hospital

OTHER

collaborator

University Hospital, Linkoeping

OTHER

collaborator

University Hospital, Umeå

OTHER

collaborator

Region Örebro County

OTHER

collaborator

Uppsala University Hospital

OTHER

lead

Uppsala University

OTHER

NCT04760184 - Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden | Biotech Hunter | Biotech Hunter